1Department of Intensive Care, Mútua Terrassa University Hospital, CIBER Enfermedades Respiratorias, Barcelona, Spain.
2Critical Care Center, Sabadell Hospital, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona, Sabadell, Spain.
3The Ohio State University Center for Biostatistics, Columbus, OH.
4Department of Surgery and Emergency Medicine, Division of Acute Care Surgery, Surgical/Trauma Critical Care, Barnes Jewish Hospital, Washington University, St. Louis, MO.
5California Pacific Medical Center, San Francisco, CA.
6Brown University/Rhode Island Hospital, Providence, RI.
7Cooper University Hospital, Camden, NJ.
* See also p. 1931.
Dr. Levy had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (http://journals.lww.com/ccmjournal).
Initial funding for the Surviving Sepsis Campaign (from 2002 to 2006) was through unrestricted educational grants from Eli Lilly, Edwards Lifesciences, Phillips Medical Systems, and the Coalition for Critical Care Excellence (Society of Critical Care Medicine). There was no involvement by the sponsors in the development, data analysis, or manuscript preparation of the current study. No additional funding has been received since that time or during the analysis and development of the current study and manuscript.
Dr. Ferrer served as board member for Laboratorios Ferrer and lectured for Merck, Sharp and Dohme, and Pfizer. His institution received grant support from Instituto de Salud Carlos III. Mr. Phillips received support for participation in review activities from the Rhode Island Hospital, a Lifespan Partner. His institution received grant support from the National Institutes of Health Grant and Murdoch Children’s Research Institution. Dr. Osborn consulted for Institute of Healthcare Improvement (sepsis consultant on quality initiative); and received support for travel from American College of Emergency Physicians (Scientific Assembly 2011, 2012, 2013. Dr. Townsend received support for article research from the Gordon and Betty Moore Foundation. Dr. Dellinger received support for travel for the meeting of Surviving Sepsis Campaign (SSC) steering committee. Dr. Artigas served as board member for Ferrer Farma, consulted for Hill Rom, and lectured for Pulsion. His institution received grant support from Pulsion. The remaining authors have disclosed that they do not have any potential conflicts of interest.
For information regarding this article, E-mail: [email protected]
